Collaborative study on the expression of irregular erythrocyte antibody following erythrocyte transfusion

Prospective collaborative study on the expression of irregular erythrocyte antibody following erythrocyte transfusion - Prospective study on post-transfusion irregular erythrocyte antibody

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036980

Enrollment

500

Registered

2019-06-10

Start date

2019-06-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients received blood transfusion

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients transfused for the first time in each institute. 2) Patients received examination for erythrocyte irregular antibody. 3) Written informed consent received from the patient or his/her family.

Exclusion criteria

Exclusion criteria: 1) Rejected his/her informed consent after started this study. 2) The institutional head makes negative decision on this study.

Design outcomes

Primary

Measure	Time frame
1) Erythrocyte irregular antibodies detected following blood transfusion. 2) Factors related seroconversion of antibody following blood transfusion, including sex, age, primary disease, previous transfusion history, amounts of erythrocyte transfused (units) etc.	—

Countries

Japan

Contacts

Public ContactHarumi Fujihara

Hamamatsu University School of Medicine Transfusion and Cell Therapy

haru@hama-med.ac.jp053-435-2111

Outcome results